Uzbekistan Medical Device Registration Project Timeline: Planning the Real Duration

1. Key takeaways

The true duration of a medical device registration project in Uzbekistan equals the preparation segment (authentication plus translation plus samples), plus the statutory review period (15, 30, 60, 90, or 120 working days), plus the deficiency correction segment (up to 60 working days per round, with the clock suspended during the response). Of the three segments, only the middle one carries an official figure; the first and last are determined by the quality of project execution. The GRZAN scheduling method is to fix the statutory tier first, then add the two incompressible segments of authentication and samples using critical path methods, and finally reserve flexible time for clinical studies and inspections as contingencies that may be triggered. A plan built this way survives contact with the regulator far better than one built on the statutory number alone.

Treated this way, the project timeline stops being a single estimate and becomes a small model with three inputs that can each be improved: the preparation segment shrinks through parallel execution of authentication and translation, the statutory segment shrinks through pathway and class selection, and the correction segment shrinks through pre-submission consistency work. Management attention is best spent on the third input, because it is the one that most often turns a predictable project into a delayed one, and because the same consistency discipline also improves the quality of the registration that is ultimately granted.

The three-segment model also produces better customer communication. Quotations built on the statutory figure alone create expectations that the process cannot meet, while quotations that show the preparation segment, the statutory tier, and a correction reserve demonstrate that the timeline is engineered rather than guessed. Where the recognition pathway is available, the model also quantifies its benefit honestly: not a magic 15 days from signature to certificate, but the removal of the local testing, clinical, and inspection segments whose duration no one can promise in advance.

2. Legal basis

3. Expert insights

Insight one: the value of the recognition pathway is not the 15 days but the removal of the uncontrollable segments. On the general pathway, the start of local laboratory testing, clinical studies, and manufacturing inspections depends on the judgment of the center and is therefore uncertain; on the recognition pathway these three items are usually exempted, which makes the project duration predictable. For projects with a fixed launch date, predictability is often commercially more valuable than a nominally shorter period.

Insight two: the authentication chain should run in parallel with dossier preparation, not in series. The content of the authorization letter (the parties, the scope of authority, the product range, the validity period) can be fixed early in dossier preparation, so authentication can start before the technical documents are finalized. A serial sequence of finalizing the dossier first and then executing the notarization and authentication adds several weeks to the project for no regulatory benefit.

Insight three: correction rounds are the variable that most needs managing and is most often overlooked. Because the clock is suspended during corrections, every round consumes additional calendar time outside the statutory period. Completing cross-document consistency checks before submission is the most effective way to compress the total duration, because it can turn two correction rounds into zero.

Insight four: the external deadline of July 1, 2027 works backward into 2026 project schedules. If the system certificate requires local recognition or conversion, the work of obtaining the national ISO:13485 certificate of conformity must be completed in the first half of 2027, and the corresponding preparation must start within 2026. This deadline is especially critical for companies with multi-product portfolios, which need to cover the manufacturing sites and product families of all marketed products in one effort.

4. Practical recommendations

1. Build the schedule in three segments of preparation, statutory review, and correction, marking the responsible party and the time unit (calendar days or working days) for each.
2. Start authentication in parallel with dossier preparation, and confirm the authorization letter template before the technical documents are finalized.
3. Maintain a document identity list (manufacturer, certificate holder, applicant, representative, manufacturing site, model, GMDN code, UDI code, software version, shelf life) for pre-submission consistency checks.
4. Reserve flexible time for clinical studies and manufacturing inspections as contingencies that may be triggered, not as fixed durations.
5. For multi-product companies, plan the coverage of system certificates uniformly against July 1, 2027, to avoid repeated per-product investment.

5. Verification checklist

• □ The schedule is built in the three segments of preparation, statutory review, and correction
• □ Authentication and dossier preparation are started in parallel
• □ A document identity list is maintained and used for pre-submission consistency checks
• □ Flexible time for clinical studies and manufacturing inspections is reserved as a contingency that may be triggered
• □ Recognition-pathway projects confirm the exemption of the three local steps (testing, clinical studies, inspections)
• □ Multi-product companies plan system certificate coverage uniformly against July 1, 2027

GRZAN provides registration support in Uzbekistan for manufacturers, importers, and authorized representatives, covering end-to-end project scheduling and dossier management. For assistance, contact info@grzanglobal.com.

Regulatory information verified as of October 29, 2026.